e-learning
resources
Munich 2006
Monday 04.09.2006
Cystic fibrosis lung disease: infection, inflammation or both?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diagnostic and therapeutic difficulties in pulmonary aspergillosis (PA) in paediatric cystic fibrosis (CF) patients
I. De Schutter, E. De Wachter, C. Ernst, A. Goossens, A. Malfroot (Brussels, Belgium)
Source:
Annual Congress 2006 - Cystic fibrosis lung disease: infection, inflammation or both?
Session:
Cystic fibrosis lung disease: infection, inflammation or both?
Session type:
Thematic Poster Session
Number:
2800
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. De Schutter, E. De Wachter, C. Ernst, A. Goossens, A. Malfroot (Brussels, Belgium). Diagnostic and therapeutic difficulties in pulmonary aspergillosis (PA) in paediatric cystic fibrosis (CF) patients. Eur Respir J 2006; 28: Suppl. 50, 2800
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Macrolides in cystic fibrosis (CF); clinical experience
Source: Eur Respir J 2004; 24: Suppl. 48, 615s
Year: 2004
Omalizumab for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in children with cystic fibrosis (CF)
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
High frequency chest wall oscillation (HFCWO) in the treatment of acute pulmonary exacerbation in adult cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010
The oral AntibioticS approprIateness score (OASIS) – A novel scoring system to assess antibiotic route in pulmonary exacerbations of cystic fibrosis (CF)
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Therapeutic options and management of pulmonary fibrosis: old and new
Source: Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005
Year: 2005
Indicators of pulmonary exacerbation in adults with cystic fibrosis (CF)
Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Year: 2011
Scedosporium species (Sspp) in patients with cystic fibrosis (CF): Implications for clinical practice
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Magnetic-resonance-imaging (MRI) for assessment of regional therapy response in patients with cystic fibrosis (CF)
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
Clinical experience with Nintedanib for treatment of idiopathic pulmonary fibrosis (IPF) in Spain.
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
Breathing pattern during rest and exercise in patients with cystic fibrosis (CF), pulmonary fibrosis (PF) and COPD before lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 685s
Year: 2005
Respiratory infections in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009
Microbial findings in children with cystic fibrosis. The value of bronchoscopy
Source: Annual Congress 2005 - Paediatric bronchology - a broad field
Year: 2005
Non-cystic fibrosis bronchiectasis in children
Source: Annual Congress 2005 - MP11 - Non-cystic fibrosis bronchiectasis in children
Year: 2005
Monitoring small airways disease (SAD) in cystic fibrosis (CF)
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011
Pulmonary tuberculosis (TB) as a complication of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009
Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients?
Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
Effect of recurrent growth of aspergillus on lung function in paediatric population with cystic fibrosis (CF)
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept